Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic ...

The data raise questions about valve hemodynamics and the role of early imaging to stay ahead of clinical and subclinical ...

Medtronic plc released positive results from a two-year trial of Evolut TAVR that demonstrated superior valve performance in patients with small aortic annuli. The SMall Annuli Randomized To Evolut or ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Aortic dissection is a life-threatening condition with complex immunological underpinnings.